ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO

Enzyme Immunoassay, Benzodiazepine

PRINCETON BIOMEDITECH CORP.

The following data is part of a premarket notification filed by Princeton Biomeditech Corp. with the FDA for Accusign Bzo, Biosign Bzo, Status Bzo.

Pre-market Notification Details

Device IDK991079
510k NumberK991079
Device Name:ACCUSIGN BZO, BIOSIGN BZO, STATUS BZO
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant PRINCETON BIOMEDITECH CORP. 4242 U.S. ROUTE 1 P.O. BOX 7139 Monmouth Junction,  NJ  08852 -1905
ContactJemo Kang
CorrespondentJemo Kang
PRINCETON BIOMEDITECH CORP. 4242 U.S. ROUTE 1 P.O. BOX 7139 Monmouth Junction,  NJ  08852 -1905
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-03-26
Decision Date1999-04-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.